• Polygodial: TRPA1 Channel Activator

  2026-08-26

  Polygodial is a TRPA1 channel activator used to perturb sensory ion-channel signaling in research assays. Its defined chemical identity, DMSO solubility, and cold-storage requirements support controlled membrane transporter and neurophysiology workflows.

• Tioconazole: Translational Strategy for Antifungal Research

  2026-08-26

  A thought-leadership guide to using Tioconazole as a mechanistic reference in antifungal drug development, with practical assay design, metabolic-stress considerations, and translational decision points informed by recent DNA-repair research.

• SCH772984: An ERK1/2 Lens on Radioresistance

  2026-08-25

  A translational framework for using SCH772984 to test whether ERK1/2 activity connects angiotensin II, HIF-1α-HILPDA signaling, ferroptosis suppression, and radioresistance in nasopharyngeal carcinoma.

• Magnetic In Vivo CAR-T Mimicry for Solid Tumors

  2026-08-25

  The Advanced Materials study introduces a magnetic bispecific nano-antibody that engages endogenous T cells in vivo and guides the resulting CAR-T-mimicking cells toward solid tumors. Its significance lies in combining antibody-mediated T-cell activation with external magnetic navigation, addressing two major barriers in solid-tumor immunotherapy: poor infiltration and local immunosuppression.

• DiI (DiIC18(3)) Plasma Membrane Probe

  2026-08-24

  DiI (DiIC18(3)) provides orange-red fluorescence for tracking plasma membrane boundaries, lateral membrane movement, and labeled cells in live or fixed samples. It is supplied as an organic-solvent-compatible lipophilic dye, so it should not be added directly to water-based protocols or treated as a general intracellular organelle stain.

• In Vitro Drug Response Metrics in Cancer Research

  2026-08-23

  Hannah R. Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a measurement framework that separates proliferative arrest from cell killing and emphasizes their different proportions and timing, improving interpretation of in vitro drug-response data.

• PTEN mRNA: A Translational Route to Resistance

  2026-08-22

  A mechanistic and strategic guide to using EZ Cap™ Human PTEN mRNA (ψUTP) to study PTEN restoration, PI3K/Akt signaling pathway inhibition, and therapeutic resistance in translational cancer research.

• Pam3CSK4 TFA: Designing Better TLR1/2 Assays

  2026-08-21

  Pam3CSK4 TFA is a defined TLR1/2 agonist for dissecting innate immune signaling. This guide explains how to use it as a controlled perturbation tool, interpret cytokine responses, and translate maternal-neonatal findings into stronger assay designs.

• Polygodial: A TRPA1 Assay Design Framework

  2026-08-20

  Polygodial provides a chemically defined route to TRPA1 channel activation and mechanistic studies of calcium-dependent signaling. This article connects product handling with the TRPA1–Ca2+–NFAT–TSLP axis, helping researchers distinguish direct channel responses from downstream epithelial inflammation.

• Hexa His tag peptide for Cleaner Protein IP

  2026-08-20

  Hexa His tag peptide enables competitive, antibody-sparing elution of His-tagged proteins from immunoprecipitation workflows. This guide connects cleaner recovery with CARMIL–capping protein studies, offering practical starting conditions, assay controls, and troubleshooting strategies.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-08-19

  Learn how Aconitase Activity Colorimetric Assay Kit, SKU K2226, can add a functional TCA-cycle and oxidative-stress endpoint to cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers assay principle, sample compatibility, protocol controls, interpretation, and practical vendor selection.

• Rocilinostat (ACY-1215): HDAC6 Inhibitor Evidence

  2026-08-19

  Rocilinostat, also called ACY-1215, is a selective HDAC6 inhibitor with a reported biochemical IC50 of 5 nM. Preclinical multiple myeloma studies associate HDAC6 inhibition with increased α-tubulin acetylation, reduced tumor-cell viability, and enhanced activity with proteasome inhibitors.

• AZD8055 Protocol Guide for mTOR Inhibition

  2026-08-18

  AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling in cancer and metabolic models. This guide covers solvent handling, assay setup, pathway-specific QC, and interpretation limits; it is not intended to support clinical efficacy claims or experiments requiring a water-soluble compound.

• Amphotericin B: Sterol Biology for Better Assays

  2026-08-18

  Explore how Amphotericin B converts fungal membrane sterol biology into a rigorous experimental framework. This article connects sterol-state control, orthogonal readouts, immune signaling, and recent Candida albicans combination research to improve assay interpretation.

• Lysis Buffer for Mouse Genotyping Workflows

  2026-08-17

  Turn small tail, toe, or ear samples into usable genomic DNA with a focused workflow built around a rapid genotyping kit component. This guide covers protocol setup, assay selection, model-bridging applications, and practical troubleshooting for reliable mouse genotyping.

441 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page